New Council of Europe resolution will promote pharmaceutical care in Europe
A new Council of Europe resolution on the implementation of pharmaceutical care for the benefit of patients and health services1 has been adopted by the Committee of Ministers of the Council of Europe to improve the medication use process and quality of care across Europe.
The resolution defines a framework for promoting and implementing the concept of pharmaceutical care in health systems at national level. The concept of pharmaceutical care encourages pharmacists to use their expertise and that of the pharmacy team to contribute to appropriate use of medicines and health promotion, both locally and nationally.
The resolution uses Hepler’s and Strand’s definition of pharmaceutical care. According to this definition, pharmaceutical care is “the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient’s quality of life” and it “involves the process through which a pharmacist cooperates with a patient and other professionals in designing, implementing and monitoring a therapeutic plan that will produce specific therapeutic outcomes for the patient”.2
The resolution was prepared by an ad-hoc working party composed of hospital and community pharmacists, academics and representatives of national competent authorities, which was overseen by the Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH) of the Council of Europe.
The resolution will provide health authorities across Europe with guidance and recommendations supporting the promotion and implementation of pharmaceutical care as a quality-enhancing element in healthcare systems at regional and national level.
Caroline Larsen Le Tarnec, Public Relations Division, EDQM, Council of Europe. Tel.: +33 (0) 3 88 41 28 15 – E-mail: firstname.lastname@example.org
Note for the Editor: Further information is available on the internet site https://www.edqm.eu/.
1. Resolution CM/Res(2020)3 on the implementation of pharmaceutical care for the benefit of patients and health services.
2. Hepler C.D. and Strand L.M., “Opportunities and Responsibilities in Pharmaceutical Care”, American Journal of Hospital Pharmacy 1990; 47: 533-43.